Towa Pharmaceutical Co Ltd 2023 Integrated Report
Company: Towa Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2023
Type: Integrated Report
Pages: 58
The report describes Towa Group’s efforts to expand generics production capacity while maintaining stable supply, alongside growth in health-related businesses. For the fiscal year under review, the group recorded net sales of JPY 208,859 million. It also disclosed a target to reduce Scope 1 and 2 emissions by 30% by FY2030 compared with FY2021, and to achieve carbon neutrality by FY2050.
Services
From bulk PDFs to structured indicators and machine-readable documents.